Human Neural Precursors from CNS Developmental Disorders: Down Syndrome
Human Neural Precursors from CNS Developmental Disorders: Down Syndrome
批准号:
7470915
负责人:
VOLNEY L SHEEN
金额:
$21.25万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-04 至 2010-03-31
关键词:
ARNT2 geneAdoptedAgeAlzheimer&aposs DiseaseAmyloid beta-Protein PrecursorBrainCalcium-Binding ProteinsCell DeathCell LineCharacteristicsChromosomes, Human, Pair 21Congenital AbnormalityCongenital Heart DefectsDataDefectDevelopmentDiseaseDown SyndromeFaceFinancial compensationFree RadicalsGene DuplicationGene ExpressionGene Expression ProfileGenesGenomeGoalsHIF1A geneHearing problemHumanHuman BiologyHuman IdentificationsIn VitroIndividualInfectionInjuryLeadMediatingMental RetardationMessenger RNAModelingMolecularMolecular ProfilingNetwork-basedNeurologicNeuronsPathway AnalysisPathway interactionsPhenotypePopulationProcessProteinsPublic HealthReactive Oxygen SpeciesResearchSamplingSeizuresTechniquesTechnologyTestingTherapeutic InterventionTissuesUp-RegulationVisionaquaporin 4brain tissuecell typedevelopmental diseasehuman stem cellsinsightmRNA Expressionmouse Trisomy 16mouse modelnerve stem cellnormal agingnovel therapeuticsprogenitorrelating to nervous systemresponsetherapeutic targetwater channel
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Down syndrome (DS) is a common developmental disorder caused by a duplication of chromosome 21. Understanding the developmental mechanisms that lead to the primary neurological features of DS, namely MR, seizures, and premature Alzheimer's disease (AD), will depend upon characterization of the differences observed in the development of the DS, as opposed to normal brain. Various mouse models have been used as experimental paradigms to understand such differences, but clear limitations exist in the interpretation of these studies, particularly since the biology of human brains are different from those of other species. Moreover, many of the neuropathological features of DS brain namely altered proliferation, cell death, and neuronogenesis suggest a defect within the neural stem cell (NSC) population. Thus, we propose to investigate the mRNA profiles of human NSCs derived from Down syndrome brain and characterize the cellular and molecular factors which are disrupted in this vitro developmental model. We hypothesize that altered expression of genes on chromosome 21 in human DS NSCs will lead to identifiable mRNA expression changes throughout the genome, and that these changes can be associated with specific functional pathways that will contribute to the DS CNS phenotype. We propose a two-part study involving human DS neural progenitors, to investigate the mechanisms of DS cortical development: Specific Aim 1: Using validated techniques of quantitative mRNA profiling technology, we will identify genes altered on mRNA expression profiles of multiple human DS neural progenitor lines as compared to age-matched controls and use network analysis to identify interacting proteins and developmental pathways important for DS. Specific Aim 2: We will test whether the functional changes predicted in the prior aim are apparent in the DS NSCs and human or trisomy 16 mouse tissues. Through quantitative mRNA analyses of fairly uniform human DS neural progenitors and functional analyses of DS neural precursors in vitro, we hope to gain additional insight into mechanisms underlying this common disorder and provide potential venues for the discovery of new therapeutic targets. PUBLIC HEALTH RELEVANCE Down Syndrome (DS) is one of the most common developmental disorders in humans and is caused by the abnormal duplication of genes on chromosome 21. The current proposal seeks to generate and study human stem cells from DS brain. Understanding the genes which are disrupted in this disorder will allow for the development of therapeutic interventions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Down Syndrome: a potential treatment XISTs
-
批准号:10525816
-
项目类别:
-
资助金额:$169.33万
-
财政年份:2022
-
负责人:VOLNEY L SHEEN
-
依托单位:
Epigenetic Silencing of HSA21 in Down Syndrome
-
批准号:10016836
-
项目类别:
-
资助金额:$26.25万
-
财政年份:2019
-
负责人:VOLNEY L SHEEN
-
依托单位:
Deciphering HSA21 genes associated with Alzheimers disease in Down Syndrome
-
批准号:10120793
-
项目类别:
-
资助金额:$28.19万
-
财政年份:2019
-
负责人:VOLNEY L SHEEN
-
依托单位:
Epigenetic Silencing of HSA21 in Down Syndrome
-
批准号:9892127
-
项目类别:
-
资助金额:$21.88万
-
财政年份:2019
-
负责人:VOLNEY L SHEEN
-
依托单位:
Cellular and Molecular Mechanisms in Periventricular Heterotopia
-
批准号:8269069
-
项目类别:
-
资助金额:$29.16万
-
财政年份:2009
-
负责人:VOLNEY L SHEEN
-
依托单位:
Cellular and Molecular Mechanisms in Periventricular Heterotopia
-
批准号:7729307
-
项目类别:
-
资助金额:$29.75万
-
财政年份:2009
-
负责人:VOLNEY L SHEEN
-
依托单位:
Cellular and Molecular Mechanisms in Periventricular Heterotopia
-
批准号:8470253
-
项目类别:
-
资助金额:$28.13万
-
财政年份:2009
-
负责人:VOLNEY L SHEEN
-
依托单位:
Cellular and Molecular Mechanisms in Periventricular Heterotopia
-
批准号:8078196
-
项目类别:
-
资助金额:$29.16万
-
财政年份:2009
-
负责人:VOLNEY L SHEEN
-
依托单位:
Human Neural Precursors from CNS Developmental Disorders: Down Syndrome
-
批准号:7602965
-
项目类别:
-
资助金额:$25.5万
-
财政年份:2008
-
负责人:VOLNEY L SHEEN
-
依托单位:
The Role of Filamin in Periventricular Heterotopias
-
批准号:6361362
-
项目类别:
-
资助金额:$16.99万
-
财政年份:2001
-
负责人:VOLNEY L SHEEN
-
依托单位:
The Role of Filamin in Periventricular Heterotopias
-
批准号:6755157
-
项目类别:
-
资助金额:$17.15万
-
财政年份:2001
-
负责人:VOLNEY L SHEEN
-
依托单位:
The Role of Filamin in Periventricular Heterotopias
-
批准号:6896101
-
项目类别:
-
资助金额:$17.15万
-
财政年份:2001
-
负责人:VOLNEY L SHEEN
-
依托单位:
The Role of Filamin in Periventricular Heterotopias
-
批准号:6539295
-
项目类别:
-
资助金额:$17.15万
-
财政年份:2001
-
负责人:VOLNEY L SHEEN
-
依托单位:
The Role of Filamin in Periventricular Heterotopias
-
批准号:6608616
-
项目类别:
-
资助金额:$17.15万
-
财政年份:2001
-
负责人:VOLNEY L SHEEN
-
依托单位:
LOCAL MICROENVIRONMENTAL CONTROL OF NEURAL SPECIFICATION
-
批准号:2430901
-
项目类别:
-
资助金额:$0.14万
-
财政年份:1997
-
负责人:VOLNEY L SHEEN
-
依托单位:
LOCAL MICROENVIRONMENTAL CONTROL OF NEURAL SPECIFICATION
-
批准号:2242517
-
项目类别:
-
资助金额:$2.47万
-
财政年份:1996
-
负责人:VOLNEY L SHEEN
-
依托单位:
LOCAL MICROENVIRONMENTAL CONTROL OF NEURAL SPECIFICATION
-
批准号:2242516
-
项目类别:
-
资助金额:$2.35万
-
财政年份:1995
-
负责人:VOLNEY L SHEEN
-
依托单位:
海外基金